Summary
5.49 -0.01(-0.09%)10/04/2024
Aurora Cannabis Inc (ACB)
Aurora Cannabis Inc (ACB)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -0.09 | -6.32 | -3.26 | 13.33 | -22.31 | 891.86 | -89.61 | -48.75 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 5.49 | |
| Open | 5.55 | |
| High | 5.64 | |
| Low | 5.45 | |
| Volume | 588,918 | |
| Change | -0.00 | |
| Change % | -0.09 | |
| Avg Volume (20 Days) | 698,988 | |
| Volume/Avg Volume (20 Days) Ratio | 0.84 | |
| 52 Week Range | 0.37 - 9.35 | |
| Price vs 52 Week High | -41.34% | |
| Price vs 52 Week Low | 1,382.43% | |
| Range | -1.17 | |
| Gap Up/Down | 0.00 | |
Fundamentals | ||
| Market Capitalization (Mln) | 314 | |
| EBIDTA | 0 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 6.58 | |
| Book Value | 10.2210 | |
| Earnings Per Share | -2.5150 | |
| EPS Estimate Current Quarter | -0.2100 | |
| EPS Estimate Next Quarter | -0.1900 | |
| EPS Estimate Current Year | 0.0000 | |
| EPS Estimate Next Year | 0.0000 | |
| Diluted EPS (TTM) | -2.5150 | |
| Revenues | ||
| Profit Marging | -2.5470 | |
| Operating Marging (TTM) | -1.1936 | |
| Return on asset (TTM) | -0.0667 | |
| Return on equity (TTM) | -0.2904 | |
| Revenue TTM | 237,767,008 | |
| Revenue per share TTM | 1.2560 | |
| Quarterly Revenue Growth (YOY) | -0.1110 | |
| Quarterly Earnings Growth (YOY) | -0.9170 | |
| Gross Profit (TTM) | -21,558,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 0.7581 | |
| Revenue Enterprise Value | 5.2308 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 198,228,000 | |
| Shares Float | 198,105,126 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.03 | |
| Institutions (%) | 19.76 | |
10/03 11:29 EST - benzinga.com
Profit from the Green Wave: Top Cannabis Stocks to Watch
The cannabis sector has captivated investors, promising a green rush of potential profits. However, the path to profitability has been rocky, marked by regulatory hurdles, intense competition, and, at times, a volatile market.
Profit from the Green Wave: Top Cannabis Stocks to Watch
The cannabis sector has captivated investors, promising a green rush of potential profits. However, the path to profitability has been rocky, marked by regulatory hurdles, intense competition, and, at times, a volatile market.
10/03 10:50 EST - zacks.com
ACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project
Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas.
ACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project
Aurora Cannabis' new collaboration on the Genome BC-Funded Project addresses distinct cannabis aromas.
10/02 07:00 EST - prnewswire.com
Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas
NASDAQ | TSX: ACB Research Project designed to validate breeding genetics connected with fruity aroma, a key patient and consumer preference trait, with positive impact on future innovation EDMONTON, AB , Oct. 2, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –—the Canadian based leading global medical cannabis company, today announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia (Genome BC), a not-for-profit organization supporting world-class genomics research and innovation in British Columbia. The project, Genomics-enabled Aroma Breeding in Cannabis, will directly support Aurora's genetics work the project, is led by Drs.
Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas
NASDAQ | TSX: ACB Research Project designed to validate breeding genetics connected with fruity aroma, a key patient and consumer preference trait, with positive impact on future innovation EDMONTON, AB , Oct. 2, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –—the Canadian based leading global medical cannabis company, today announced a research grant provided to the University of British Columbia (UBC) by Genome British Columbia (Genome BC), a not-for-profit organization supporting world-class genomics research and innovation in British Columbia. The project, Genomics-enabled Aroma Breeding in Cannabis, will directly support Aurora's genetics work the project, is led by Drs.
09/20 07:00 EST - prnewswire.com
Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors
NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB , Sept. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director.
Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors
NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB , Sept. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director.
09/19 10:00 EST - marijuanastocks.com
Canadian Cannabis Stocks Set to Soar Right Now
The Canadian cannabis market remains a focal point for investors this week, especially with companies expanding into the U.S. market. Recently, the U.S. cannabis industry has shown remarkable growth, with sales projected to reach $45 billion by 2025. This expansion offers Canadian companies a gateway to a larger consumer base. The increasing push for legalization in the U.S. is also a significant factor. States are continuously passing legislation to legalize cannabis for recreational and medicinal use. Therefore, investors watch how Canadian stocks position themselves for potential U.S. market entry.
Canadian Cannabis Stocks Set to Soar Right Now
The Canadian cannabis market remains a focal point for investors this week, especially with companies expanding into the U.S. market. Recently, the U.S. cannabis industry has shown remarkable growth, with sales projected to reach $45 billion by 2025. This expansion offers Canadian companies a gateway to a larger consumer base. The increasing push for legalization in the U.S. is also a significant factor. States are continuously passing legislation to legalize cannabis for recreational and medicinal use. Therefore, investors watch how Canadian stocks position themselves for potential U.S. market entry.
09/17 07:00 EST - prnewswire.com
Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence
Auto-Flowering Breakthroughs Poised to Transform Cannabis Cultivation in High-Latitude Regions, Opening New Doors for Advanced Breeding Strategies EDMONTON, AB , Sept. 17, 2024 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pioneering ground-breaking research in auto-flowering technology.
Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence
Auto-Flowering Breakthroughs Poised to Transform Cannabis Cultivation in High-Latitude Regions, Opening New Doors for Advanced Breeding Strategies EDMONTON, AB , Sept. 17, 2024 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pioneering ground-breaking research in auto-flowering technology.
09/10 09:15 EST - 247wallst.com
Prediction: 4 Stocks That Will Pop If Kamala Harris Wins
24/7 Wall St. Insights A Kamala Harris victory in the 2024 presidential election could provide a boost for stocks in a variety of sectors.
Prediction: 4 Stocks That Will Pop If Kamala Harris Wins
24/7 Wall St. Insights A Kamala Harris victory in the 2024 presidential election could provide a boost for stocks in a variety of sectors.
09/09 07:03 EST - globenewswire.com
Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge
Launch represents Vectura Fertin Pharma's first medical cannabis CBD lozenge to be introduced in Canada Launch follows announcement of commercial collaboration between Cogent International, a Vectura Fertin Pharma subsidiary, and Aurora to leverage Aurora's Canadian medical cannabis patient platform Collaboration will explore the potential to launch Vectura Fertin Pharma's future medical cannabis portfolio in Canada Edmonton, AB, and Stamford, CT – September 9, 2024 - Aurora Cannabis Inc. ("Aurora") (NASDAQ | TSX: ACB), a leading Canadian-based global medical cannabis company, and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, are pleased to announce the launch of the newly developed Luo CBD lozenge. The high-quality CBD lozenge was developed by Vectura Fertin Pharma and adheres to stringent safety, quality and regulatory standards to address unmet medical and health needs.
Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge
Launch represents Vectura Fertin Pharma's first medical cannabis CBD lozenge to be introduced in Canada Launch follows announcement of commercial collaboration between Cogent International, a Vectura Fertin Pharma subsidiary, and Aurora to leverage Aurora's Canadian medical cannabis patient platform Collaboration will explore the potential to launch Vectura Fertin Pharma's future medical cannabis portfolio in Canada Edmonton, AB, and Stamford, CT – September 9, 2024 - Aurora Cannabis Inc. ("Aurora") (NASDAQ | TSX: ACB), a leading Canadian-based global medical cannabis company, and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, are pleased to announce the launch of the newly developed Luo CBD lozenge. The high-quality CBD lozenge was developed by Vectura Fertin Pharma and adheres to stringent safety, quality and regulatory standards to address unmet medical and health needs.
09/06 09:24 EST - marijuanastocks.com
3 Marijuana Stocks To Watch In The Stock Market Today
Many legal cannabis operators are working to keep pushing the boundaries of the industry. Innovation is key for any growing sector and cannabis is no different. Right now is a pivotal time for the cannabis industry as things are continuously changing. The climate of the sector and the success of companies can have a direct connection to how most marijuana stocks perform, especially during an election year where promises may come along from presidential candidates to better the industry.
3 Marijuana Stocks To Watch In The Stock Market Today
Many legal cannabis operators are working to keep pushing the boundaries of the industry. Innovation is key for any growing sector and cannabis is no different. Right now is a pivotal time for the cannabis industry as things are continuously changing. The climate of the sector and the success of companies can have a direct connection to how most marijuana stocks perform, especially during an election year where promises may come along from presidential candidates to better the industry.
09/05 09:38 EST - benzinga.com
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
The cannabis market is abuzz following former President Donald Trump's recent comments supporting cannabis legalization in Florida.
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
The cannabis market is abuzz following former President Donald Trump's recent comments supporting cannabis legalization in Florida.
09/03 09:52 EST - marketwatch.com
Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue
Alliance Global Partners Aaron Grey sees Donald Trump's weekend statement on cannabis as a step forward.
Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue
Alliance Global Partners Aaron Grey sees Donald Trump's weekend statement on cannabis as a step forward.
08/30 09:09 EST - marijuanastocks.com
Top Canadian Marijuana Stocks To Watch In 2024
When it comes to finding top marijuana stocks to buy which companies would you choose? Now when going through this process there are some things to consider. For the most part, investing in all things is based on the same basic outline which is buy low sell high do your research create a game plan be patient, and try to take profits when you can.
Top Canadian Marijuana Stocks To Watch In 2024
When it comes to finding top marijuana stocks to buy which companies would you choose? Now when going through this process there are some things to consider. For the most part, investing in all things is based on the same basic outline which is buy low sell high do your research create a game plan be patient, and try to take profits when you can.
08/27 15:12 EST - schaeffersresearch.com
3 Weed Stocks Sinking on Reclassification Hearing Update
The U.S. Drug Enforcement Administration (DEA) today announced a proposal hearing on the reclassification of marijuana as a less restricted Schedule III drug will happen on Dec. 2, after the presidential election.
3 Weed Stocks Sinking on Reclassification Hearing Update
The U.S. Drug Enforcement Administration (DEA) today announced a proposal hearing on the reclassification of marijuana as a less restricted Schedule III drug will happen on Dec. 2, after the presidential election.
08/24 07:16 EST - fool.com
Prediction: Aurora Cannabis Will Be Worth More Than Canopy Growth in 5 Years
Aurora Cannabis and Canopy Growth have been leading companies within the cannabis industry for years. Both businesses have struggled, however, and have been working on improving their financials.
Prediction: Aurora Cannabis Will Be Worth More Than Canopy Growth in 5 Years
Aurora Cannabis and Canopy Growth have been leading companies within the cannabis industry for years. Both businesses have struggled, however, and have been working on improving their financials.
08/16 07:30 EST - fool.com
Aurora Cannabis Had a Strong Q1, but Investors Should Expect a Slowdown in Future Quarters
Aurora Cannabis has made significant strides in improving its financials. The company generated positive free cash flow and revenue rose last quarter.
Aurora Cannabis Had a Strong Q1, but Investors Should Expect a Slowdown in Future Quarters
Aurora Cannabis has made significant strides in improving its financials. The company generated positive free cash flow and revenue rose last quarter.
08/13 13:08 EST - proactiveinvestors.com
Cannabis MSOs embrace new markets, streamline operations in Q2
Earnings from North American cannabis companies for the second quarter have been a mixed bag, with expansion into new markets, operational streamlining, and product innovation key themes across the sector. Many multi-state operations (MSOs) are turning to emerging, less saturated international markets for growth, notably, Germany, which kicked off expanded medical sales amid broader legalization measures on April 1.
Cannabis MSOs embrace new markets, streamline operations in Q2
Earnings from North American cannabis companies for the second quarter have been a mixed bag, with expansion into new markets, operational streamlining, and product innovation key themes across the sector. Many multi-state operations (MSOs) are turning to emerging, less saturated international markets for growth, notably, Germany, which kicked off expanded medical sales amid broader legalization measures on April 1.
08/12 07:00 EST - prnewswire.com
Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting
NASDAQ | TSX: ACB EDMONTON, AB , Aug. 12, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of the record date.
Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting
NASDAQ | TSX: ACB EDMONTON, AB , Aug. 12, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of the record date.
08/09 11:42 EST - marketbeat.com
The Cannabis Sector: Profitability Takes Center Stage
The cannabis industry has experienced significant change since its inception twelve years ago. Fueled by legalization trends and evolving social acceptance, this burgeoning sector has attracted considerable investment and innovation.
The Cannabis Sector: Profitability Takes Center Stage
The cannabis industry has experienced significant change since its inception twelve years ago. Fueled by legalization trends and evolving social acceptance, this burgeoning sector has attracted considerable investment and innovation.